Mohammad H Ghazimoradi
Overview
Explore the profile of Mohammad H Ghazimoradi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Motamed R, Jabbari K, Sheikhbahaei M, Ghazimoradi M, Ghodsi S, Jahangir M, et al.
Sci Rep
. 2025 Feb;
15(1):6593.
PMID: 39994414
Mesenchymal stem cells (MSCs) have emerged as crucial players within the tumor microenvironment (TME), contributing through their paracrine secretome. Depending on the context, the MSC-derived secretome can either support or...
2.
Farahani M, Ghazimoradi M
Pathol Res Pract
. 2024 Sep;
262:155576.
PMID: 39232286
Cancer-associated fibroblasts are the most important cellular component of the tumor microenvironment, controlling cancer progression and therapeutic response. These cells in the tumor microenvironment regulate tumor progression and development as...
3.
Almouh M, Pakravan K, Ghazimoradi M, Motamed R, Bakhshinejad B, Hassan Z, et al.
Mol Cell Biochem
. 2024 Feb;
479(12):3375-3391.
PMID: 38349465
Mesenchymal stem cells (MSCs) may play a pivotal role in shaping the tumor microenvironment (TME), influencing tumor growth. Nonetheless, conflicting evidence exists regarding the distinct impacts of MSCs on tumor...
4.
Ghazimoradi M, Pakravan K, Khalafizadeh A, Babashah S
Biochem Pharmacol
. 2023 Nov;
219:115913.
PMID: 37995981
The role of cancer stem cells in metastasis, recurrence, and resistance to conventional therapies is significant. Addressing these cells could potentially decrease cancer reoccurrences and mortality rates. TET1, a crucial...
5.
Ghazimoradi M, Karimpour-Fard N, Babashah S
Genes (Basel)
. 2023 Jan;
14(1).
PMID: 36672872
Early-stage leukemia identification is crucial for effective disease management and leads to an improvement in the survival of leukemia patients. Approaches based on cutting-edge biomarkers with excellent accuracy in body...
6.
Ghazimoradi M, Hasegawa K, Zolghadr E, Montazeri S, Farivar S
Sci Rep
. 2023 Jan;
13(1):1154.
PMID: 36670207
Many attempts have been made to induce high-quality embryonic stem cells such as pluripotent stem cells and totipotent stem cells, but challenges remain to be overcome such as appropriate methods...
7.
Pakravan K, Mossahebi-Mohammadi M, Ghazimoradi M, Cho W, Sadeghizadeh M, Babashah S
J Transl Med
. 2022 Dec;
20(1):559.
PMID: 36463188
Background: Cancer-associated fibroblasts (CAFs), one of the major components of the tumor stroma, contribute to an immunosuppressive tumor microenvironment (TME) through the induction and functional polarization of protumoral macrophages. We...
8.
Ghazimoradi M, Babashah S
Front Oncol
. 2022 Sep;
12:966083.
PMID: 36132137
Multidrug resistance is one of the major obstacles in the treatment of cancers. This undesirable feature increases the mortality rate of cancers, including breast cancer. Circular RNA (CircRNA)/microRNA (miRNA)/messenger RNA...
9.
Almouh M, Razmara E, Bitaraf A, Ghazimoradi M, Hassan Z, Babashah S
Life Sci
. 2022 Sep;
309:120975.
PMID: 36126723
Aims: Circular RNAs (circRNAs) are endogenous covalently closed non-coding RNAs produced by reverse splicing of linear RNA. These molecules are highly expressed in mammalian cells and show cell/tissue-specific expression patterns....
10.
Ghazimoradi M, Khalafizadeh A, Babashah S
Stem Cell Res
. 2022 Jul;
63:102857.
PMID: 35872523
Totipotent stem cells are cells with the capacity to form an entire embryo. Many attempts have been made to convert other types of cells to totipotent stem cells which we...